Carregant...
Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications
OBJECTIVES: With new specialty drugs such as biologics available in record numbers, people with immune-mediated diseases face increasing safety risks. However, comprehensive assessments of patient safety for these new specialty drugs are lacking. We examined performance on key patient safety measure...
Guardat en:
| Publicat a: | Jt Comm J Qual Patient Saf |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7433663/ https://ncbi.nlm.nih.gov/pubmed/30686706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcjq.2018.12.003 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|